Impact of HLNatural Immune Supplement on Colds

Immune System Diseases Clinical Trial

Official title:

Evaluation of the Impact of the HLNatural, Inc. Immune Support Product in Reducing the Length of Cold Symptoms in Adults Suffering From the Common Cold

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04103099
• Other study ID #: Pro00037635
• Status: Completed
• Phase: N/A
• Start date: October 16, 2019
• Est. completion date: August 15, 2020

Study information

• Verified date: November 2021
• Source: Hawthorne Effect Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

According to the Centers of Disease Control and Prevention (CDC) adults will have an average of 2-3 colds per year. Most colds will last approximately 7-10 days. The symptoms of colds could include cough, sore throat, runny nose, body aches, fevers, headaches and fatigue. A cold can affect your activity such as going to work, interrupting your sleep and your day to day activities. The test product contains all natural ingredients which have been combined into a powder to be taken in water at the sign of a cold.

Description:

At the onset of a cold, mix 1 packet of the drink-mix product in 6-8 oz. of hot water. Drink the drink mix twice a day until symptoms are gone or 18 days, whichever comes first. 1. Complete the screening survey. 2. Sign the eConsent if approved. 3. Complete the baseline survey, demographic form, and Medication and Supplements form. 4. Receive test product and log into study portal and complete supplement receipt form. This will mark the start of your participation in this study. 5. Once you have a cold, complete the symptom survey. 6. Take test product. 7. Write down any adverse or ill effects any time after taking the test product. 8. Record if you took any additional medications or supplements daily during the course of your cold. 9. Note any final adverse events and complete the exit form.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: August 15, 2020
• Est. primary completion date: August 15, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Adult candidates in the general population who are in good health and are seeking herbal remedies to reduce the duration of their common cold symptoms when they should arise. Participants will be deemed to be in good health if they do not report any of the medical conditions asked about in the screening questionnaire.

Exclusion Criteria:

• Age < 18 years old
• Unwilling to try the test product during their first cold experience in the trial
• Has any of the following medical conditions:
• Chronic seasonal allergies
• Allergy to any of the following ingredients: Echinacea, Ivy Extract, Camu Camu, Vitamin C, Ginger, Turmeric, Zinc or a known allergy to Guar Gum, Monk Fruit, Citric Acid, Natural Flavors.
• Asthma
• Current cold infection
• Currently taking antimicrobial or antiviral medication
• Alcohol consumption more than 7 drinks per week or more than 3 drinks per occasion
• Routine recreational drug use
• Chronic renal disease
• Chronic liver disease
• Known autoimmune or immunodeficiency disorders
• Medically treated atopy or allergy
• Pregnant or breastfeeding

Related Conditions & MeSH terms

• Immune System Diseases

Intervention

Dietary Supplement:
• HLNatural Immune
Vitamin C, Echinacea, Ivy Extract, Zinc, Ginger and Turmeric in a powder form mixed with water

Locations

Country	Name	City	State
United States	Hawthorne Effect, Inc.	Lafayette	California

Sponsors (2)

Lead Sponsor	Collaborator
Hawthorne Effect Inc.	HLNatural, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (39)

Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? J Cell Physiol. 2018 Feb;233(2):830-848. doi: 10.1002/jcp.25778. Epub 2017 Mar 31. Review. — View Citation

Clinic, M. Vitamin C. 2017, October 18; Available from: https://www.mayoclinic.org/drugs-supplements-vitamin-c/art-20363932.

Fazio S, Pouso J, Dolinsky D, Fernandez A, Hernandez M, Clavier G, Hecker M. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. Phytomedicine. 2009 Jan;16(1):17-24. Epub 2006 Jul 24. — View Citation

Fonseca FN, Papanicolaou G, Lin H, Lau CB, Kennelly EJ, Cassileth BR, Cunningham-Rundles S. Echinacea purpurea (L.) Moench modulates human T-cell cytokine response. Int Immunopharmacol. 2014 Mar;19(1):94-102. doi: 10.1016/j.intimp.2013.12.019. Epub 2014 Jan 13. — View Citation

Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: Where do Americans get their nutrients? J Nutr. 2011 Oct;141(10):1847-54. doi: 10.3945/jn.111.142257. Epub 2011 Aug 24. — View Citation

Gammoh NZ, Rink L. Zinc in Infection and Inflammation. Nutrients. 2017 Jun 17;9(6). pii: E624. doi: 10.3390/nu9060624. Review. — View Citation

Grosso G, Bei R, Mistretta A, Marventano S, Calabrese G, Masuelli L, Giganti MG, Modesti A, Galvano F, Gazzolo D. Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark Ed). 2013 Jun 1;18:1017-29. Review. — View Citation

Hemilä H, Petrus EJ, Fitzgerald JT, Prasad A. Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. Br J Clin Pharmacol. 2016 Nov;82(5):1393-1398. doi: 10.1111/bcp.13057. Epub 2016 Jul 28. — View Citation

Hilding DA. Literature review: the common cold. Ear Nose Throat J. 1994 Sep;73(9):639-43, 46-7. Review. — View Citation

Hudson JB. Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases. J Biomed Biotechnol. 2012;2012:769896. doi: 10.1155/2012/769896. Epub 2011 Oct 26. Review. — View Citation

Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med. 2012;2012:841315. Epub 2012 Sep 16. — View Citation

Lang C, Röttger-Lüer P, Staiger C. A Valuable Option for the Treatment of Respiratory Diseases: Review on the Clinical Evidence of the Ivy Leaves Dry Extract EA 575®. Planta Med. 2015 Aug;81(12-13):968-74. doi: 10.1055/s-0035-1545879. Epub 2015 Apr 15. Review. — View Citation

Langley PC, Pergolizzi JV Jr, Taylor R Jr, Ridgway C. Antioxidant and associated capacities of Camu camu (Myrciaria dubia): a systematic review. J Altern Complement Med. 2015 Jan;21(1):8-14. doi: 10.1089/acm.2014.0130. Epub 2014 Oct 2. Review. — View Citation

Lexicom, Inc. Phenylephrine (systemic): Drug Information. Available from: https://www.uptodate.com/contents/phenylephrine-systemic-drug-information?search=phenylephrine%20decongestant%20adult&source=search_result&selectedTitle=3~25&usage_type=default&display_rank=3#F9504784

Lopresti AL, Hood SD, Drummond PD. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects. J Psychopharmacol. 2012 Dec;26(12):1512-24. doi: 10.1177/0269881112458732. Epub 2012 Oct 3. Review. — View Citation

Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP. Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia. 2008 Jan;79(1):53-8. Epub 2007 Aug 11. — View Citation

Matthias A, Banbury L, Stevenson LM, Bone KM, Leach DN, Lehmann RP. Alkylamides from echinacea modulate induced immune responses in macrophages. Immunol Invest. 2007;36(2):117-30. — View Citation

McMahon, G., Comparison of a Numeric and a Descriptive Pain Scale in the Occupational Medicine Setting. 2019.

Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996 Jul 15;125(2):81-8. — View Citation

Mozaffari-Khosravi H, Naderi Z, Dehghan A, Nadjarzadeh A, Fallah Huseini H. Effect of Ginger Supplementation on Proinflammatory Cytokines in Older Patients with Osteoarthritis: Outcomes of a Randomized Controlled Clinical Trial. J Nutr Gerontol Geriatr. 2016 Jul-Sep;35(3):209-18. doi: 10.1080/21551197.2016.1206762. — View Citation

Oregon State University, M.I.C. Zinc. Available from: https://lpi.oregonstate.edu/mic/minerals/zinc#reference175

Pappas, Diane E. Epidemiology, clinical manifestation, and pathogensis of rhinovirus infections. Available from: https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-pathogenesis-of-rhinovirus-infections?search=common%20cold%20cytokine&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H8

Project, R. The R Project for Statistical Computing.; Available from: https://www.R-project.org/.

Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. BMC Complement Altern Med. 2012 Jul 10;12:92. doi: 10.1186/1472-6882-12-92. — View Citation

Raman, R., MS, RD. Echinacea: Benefits, Uses, Side Effects and Dosage. . 2018, October 15; Available from: https://www.healthline.com/nutrition/echinacea#side-effects.

Sexton, D.M.M. The common cold in adults: Diagnosis and clinical features. 2018, February 22; Available from: https://www.uptodate.com/contents/the-common-cold-in-adults-diagnosis-and-clinical-features?csi=b9dba3ea-808c-423c-aa05-d1f3771bf7d5&source=contentShare.

Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007 Jul;7(7):473-80. Review. Erratum in: Lancet Infect Dis. 2007 Sep;7(9):580. — View Citation

Solomon, Daniel H. Non-selective NSAIDs: Overview of adverse effects. Available from: https://www.uptodate.com/contents/nonselective-nsaids-overview-of-adverse-effects?search=side%20effects%20of%20nsaids&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H22

Sultan MT, Butt MS, Qayyum MM, Suleria HA. Immunity: plants as effective mediators. Crit Rev Food Sci Nutr. 2014;54(10):1298-308. doi: 10.1080/10408398.2011.633249. Review. — View Citation

Thamlikitkul L, Srimuninnimit V, Akewanlop C, Ithimakin S, Techawathanawanna S, Korphaisarn K, Chantharasamee J, Danchaivijitr P, Soparattanapaisarn N. Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study. Support Care Cancer. 2017 Feb;25(2):459-464. doi: 10.1007/s00520-016-3423-8. Epub 2016 Oct 6. — View Citation

Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001 Mar;101(3):294-301. — View Citation

Van Straten M, Josling P. Preventing the common cold with a vitamin C supplement: a double-blind, placebo-controlled survey. Adv Ther. 2002 May-Jun;19(3):151-9. — View Citation

Wat D. The common cold: a review of the literature. Eur J Intern Med. 2004 Apr;15(2):79-88. — View Citation

WebMD, English Ivy: Uses, Side Effects, Interactions, Dosage, and Warning

WebMD. Ginger: Uses, Side Effects, Interactions, Dosage, and Warning.; Available from: https://www.webmd.com/vitamins/ai/ingredientmono-961/ginger.

WebMD. Zinc: Uses, Side Effects, Interactions, Dosage, and Warning.; Available from: https://www.webmd.com/vitamins/ai/ingredientmono-982/zinc.

Wessels I, Maywald M, Rink L. Zinc as a Gatekeeper of Immune Function. Nutrients. 2017 Nov 25;9(12). pii: E1286. doi: 10.3390/nu9121286. Review. — View Citation

Xu XY, Meng X, Li S, Gan RY, Li Y, Li HB. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients. 2018 Oct 19;10(10). pii: E1553. doi: 10.3390/nu10101553. Review. — View Citation

Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004 Jun 14;164(11):1237-41. — View Citation

* Note: There are 39 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Outcome of freedom of cold symptoms while consuming HLNatural Supplement	Cold symptoms will be measured until the symptoms resolve. Subjects must experience 2 of more symptoms which are: cough, hoarseness, muscle aches, nasal drainage, nasal congestion, scratchy throat, sore throat, sneezing, or an oral temperature of 37.7 C (99.9 F).	At the onset of cold symptoms the symptoms will be measured for 18 days or sooner if the symptoms resolve.
Secondary	Outcome of the severity of cold symptoms while taking HLNatural Supplement	Subjects will rate the severity of the cold symptoms using Daily Symptom Survey of each possible symptom from 0-3 (3 is severe).; Comparison against the participant's normal behavior.; Net Promoter Score.; Adverse events will be summarized.; An additional data presentation will consist of results from both Treatment and Control in similar studies appearing in the literature. There will be no formal statistical comparison of results from this study and historical studies.	The diary will be completed daily during the duration of the the subject's cold.
Secondary	Outcome of the duration of the cold symptoms while taking HLNatural Supplement	The length of time that the subject's cold will be recorded	At the onset of cold symptoms until resolution of cold symptoms
Secondary	Required Behavior	Subjects will be asked to avoid over the counter cold-relief medication. However pain relievers and fever reducers are allowed	During the duration of the cold symptoms
Secondary	Outcome all adverse events while taking HLNatural Supplement	All adverse events which are collected throughout the subjects participation will be recorded.	Throughout the study
Secondary	Outcome of natural behavior of the participants while taking in the clinical trial	All subjects will be asked to complete a screening, demographic and baseline questionnaire as well as and exit survey. The screening and baseline survey will be used to understand the subjects normal behavior with cold symptoms. The Exit study will rate the product to understand if the subject felt it helped with their cold symptoms	The subject will complete the screening, demographic and baseline surveys prior to the start of the product and the exit form at the end of the subject's cold symptoms